Jonathan M. Email & Phone Number

• Responsible for the overall operation of the health clinic & assuring compliance with regulations.
• Provide Administrative oversight & coordination between staff members & healthcare programs.
• Assist in patient intakes, follow-ups, and various performed medical procedures.
• Participate in safety and quality assurance programs. for both clinic visits and electroencephalograms (EEG) and electromyograms (EMG')
• Prepare reports and financial statistics for budget analysis.
• Researched and published patient reading material on the use of THC in the New York state medical marijuana program, including qualifying disorders, like epilepsy and the different THC: CBD ratios.

New York, New York, US

• Performed DNA sequencing for Single Nucleotide Polymorphisms (SNPs) (i.e. genetic variations in human DNA) via NGS
• Created an initial database of SNPs for “diet, lifestyle, & exercise” database with a 20% in physician/patient usage.
• Researched and translated peer-reviewed scientific articles on gene mutations for accuracy & utility into the NAG database.
• Researched and advocated for incorporating biomarkers and genomics into personalized medicine, using SQL and Python

Chicago, Illinois, US

• Medical assistant and transcriptionist, completing and coordinating patient notes in coordination with HIPAA rules.
• Completed Subject Objective Assessment Plan notes and used ICD-10 coding to enter billing into EMR systems.
• Educated patients on potential progression of pathology and the importance of medication compliance, and MOA.

Chicago, Illinois, US

• Performed Mental Status Exam
• PHQ-9 & HAM-D
• Asses ADHD Self-Reporting

Chicago, Illinois, US

• Educating patients on Novel Oral Anticoagulants versus Heparin and Coumadin
• Familiarity with FDA regulations of Clinical Trials for patients suffering from certain cancers.
• Enhancing my knowledge of Chemotherapeutic Agents and side effect profiles including Antineoplastics; Antimetabolites, Alkylating agents, Nitrosoureas, Vinka Alkaloids, and Novel Biologics (Therapeutic Antibodies)
• Drugs include Lupron in the treatment of prostate ca, Marinol, Venclexta, Empliciti, Imbruvica

Chicago, IL, US

• Performed translational researchPharmacokinetics: Bioavailability, Volumes of Distribution, Clearance rates, Half-life, Dosage calculations, Eliminations (“0” order vs 1st order), Urine pH and Drug Elimination, Phases.
• Using real world application of Enzyme Kinetics (Competitive vs Non-competitive Inhibition)

New York, NY, US

• Completed a comprehensive 4-step literature review on “The Effect of HIV Infection and HAART on Oral Microbial Colonization” which served as the foundation for multiple subsequent publications.
• Created Trial Master Files for Clinical Trials.
• Performed grant writing; successfully communicated with an Institutional Review Board (IRB) & Ethics Committee (EC) protecting human subjects and assuring compliance with state and federal regulations
• Studied diagnostic markers, epigenetic mechanisms of infection, and presented translational research.
• Practiced standard cell preparation, protein isolation purification, and separation and stability analysis.
• Published Article: Current HIV/AIDS Report. “Human microbiome and HIV/AIDS.” 2012, March 9th

New York, New York, US

• Organized data of 51,000 patients, related to “Major Bleeding Events” for Meta-Analysis of 52 clinical trials.
• Calculated incidence rates and Kaplan-Meier survival analysis among patients with upper and lower GI adverse events (hemorrhage, obstruction, perforation, etc.) with effect size related to Celebrex.
• Evaluated and compared the efficacy and safety of recent FDA approved COX-1, 2 & COX-2 selective inhibitors.
• Presented data and analysis from R & D to Health Outcomes & Economics Research and Quality Control.
• Developed a first-hand understanding of pharmaceutical FDA & EMA regulations & pharmacovigilance practices.
• Analyzed Rheumatology study protocols, case report forms, current IISR studies, with ICH-GCP & CTD.

Baltimore, Maryland, US

• Created Case Report Forms (CRF), and created Standard Operating Procedures (SOP) during lab’s inception
• Performed RT-PCR, ELISA and Western Blot in a microbiology lab, translational research
• Collaborated on data analysis and interpretation of matrix metalloproteinase expression in colonic epithelial cells
• Investigated microRNA expression in IBD patient colonic epithelium, & it’s target MIP-2alpha.
• Foundation for treatments like Natalizumab, which acts on α4-integrin, was the first such drug to be approved for Crohn's disease, but its use is limited due to the risk of progressive multifocal leukoencephalopathy.
• Introduced to a real Cellular and Molecular Biology Laboratory and performed PCR, Western Blot, and Liquid Chromatography using sterile technique

Bachelor Of Science - Bs, Molecular Biochemistry

Master Of Public Health - Mph, Biostatistics

Doctor Of Medicine - Md, Medicine